These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 17346938)

  • 1. Antimicrobial treatment for Intensive Care Unit (ICU) infections including the role of the infectious disease specialist.
    Esposito S; Leone S
    Int J Antimicrob Agents; 2007 May; 29(5):494-500. PubMed ID: 17346938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the infectious diseases specialist consultant on the appropriateness of antimicrobial therapy prescription in an intensive care unit.
    Raineri E; Pan A; Mondello P; Acquarolo A; Candiani A; Crema L
    Am J Infect Control; 2008 May; 36(4):283-90. PubMed ID: 18455049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Staphylococcal infections as an important problem in intensive therapy--own clinical observations].
    Czaban SL; Olszańska D; Siemiatkowski A
    Przegl Lek; 2006; 63(7):529-32. PubMed ID: 17203802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of microbiological diagnostics on the antimicrobial treatment of hospitalised patients with infectious disease.
    Vogel F; Lüth A; Charpentier A
    Eur J Med Res; 1996 Mar; 1(6):312-4. PubMed ID: 9367945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in antibacterial therapy against emerging bacterial pathogens.
    Pournaras S; Iosifidis E; Roilides E
    Semin Hematol; 2009 Jul; 46(3):198-211. PubMed ID: 19549574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial stewardship in the intensive care unit: a focus on potential pitfalls.
    Njoku JC; Hermsen ED
    J Pharm Pract; 2010 Feb; 23(1):50-60. PubMed ID: 21507793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial incidence and antibiotic sensitivity pattern in moderate and severe infections in hospitalised patients.
    Ghosh A; Karmakar PS; Pal J; Chakraborty N; Debnath NB; Mukherjee JD
    J Indian Med Assoc; 2009 Jan; 107(1):21-2, 24-5. PubMed ID: 19588683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial resistance in the hospital setting: impact, trends, and infection control measures.
    Stein GE
    Pharmacotherapy; 2005 Oct; 25(10 Pt 2):44S-54S. PubMed ID: 16178675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome.
    Cordery RJ; Roberts CH; Cooper SJ; Bellinghan G; Shetty N
    J Hosp Infect; 2008 Feb; 68(2):108-15. PubMed ID: 18063198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing therapy for vancomycin-resistant enterococci (VRE).
    Linden PK
    Semin Respir Crit Care Med; 2007 Dec; 28(6):632-45. PubMed ID: 18095227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The intensive care unit in antimicrobial resistance.
    Koleff MH
    Postgrad Med; 2001 Feb; 109(2 Suppl):60-9. PubMed ID: 19667559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus: relationships with antibiotic use and cost drivers.
    Mauldin PD; Salgado CD; Durkalski VL; Bosso JA
    Ann Pharmacother; 2008 Mar; 42(3):317-26. PubMed ID: 18285560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daily cost of antimicrobial therapy in patients with Intensive Care Unit-acquired, laboratory-confirmed bloodstream infection.
    Vandijck DM; Depaemelaere M; Labeau SO; Depuydt PO; Annemans L; Buyle FM; Oeyen S; Colpaert KE; Peleman RP; Blot SI; Decruyenaere JM
    Int J Antimicrob Agents; 2008 Feb; 31(2):161-5. PubMed ID: 18164599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved?
    Bhat S; Fujitani S; Potoski BA; Capitano B; Linden PK; Shutt K; Paterson DL
    Int J Antimicrob Agents; 2007 Nov; 30(5):458-62. PubMed ID: 17703923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic stewardship in the intensive care unit.
    Arnold HM; Micek ST; Skrupky LP; Kollef MH
    Semin Respir Crit Care Med; 2011 Apr; 32(2):215-27. PubMed ID: 21506058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of infections caused by drug-resistant organisms in critical care.
    Hoppe B
    Am J Crit Care; 1997 Mar; 6(2):141-4. PubMed ID: 9172851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of quantitative cultures and reduced duration of antibiotic regimens for patients with ventilator-associated pneumonia to decrease resistance in the intensive care unit.
    Chastre J; Luyt CE; Combes A; Trouillet JL
    Clin Infect Dis; 2006 Sep; 43 Suppl 2():S75-81. PubMed ID: 16894519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study.
    Florescu I; Beuran M; Dimov R; Razbadauskas A; Bochan M; Fichev G; Dukart G; Babinchak T; Cooper CA; Ellis-Grosse EJ; Dartois N; Gandjini H;
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i17-28. PubMed ID: 18684703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of empiric antibiotic use on development of infections caused by extended-spectrum beta-lactamase bacteria in a neonatal intensive care unit.
    Le J; Nguyen T; Okamoto M; McKamy S; Lieberman JM
    Pediatr Infect Dis J; 2008 Apr; 27(4):314-8. PubMed ID: 18316990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.
    Jamal W; Salama M; Dehrab N; Al Hashem G; Shahin M; Rotimi VO
    J Hosp Infect; 2009 Jul; 72(3):234-42. PubMed ID: 19493588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.